Proscia Wins 2026 MedTech Breakthrough Award for Turning the Moment of Diagnosis into Drug Development Insights

According to the National Cancer Institute, approximately 40% of men and women will be diagnosed with cancer at some point during their lifetimes (reference below). Luckily, we are getting better and better at treating cancer and, in many...

The CAP Cytopathology Committee found telepathology was the only cost effective method for ROSE (Rapid On-Site Evaluation) support of FNA/EBUS...

Investments in the millions of dollars for Series A funding continue to interest investors for AI in digital pathology. The most recent news coming from Fimmic out of Finland and their $6M raise most recently bringing their total to $11M....

Proof-of-concept research investigates whether photoacoustic imaging can be used in place of traditional tissue staining procedures during cancer surgery to determine if all of the tumor has been removed Determining where breast cancer ends...

Next generation system includes whole slide imaging automation enhancements, auto-detection for tissue AOI’s and intelligent user features for local and remote viewing OptraSCAN recently announced its next generation system at the Digital...

February 12-14, 2018   |   Moscone South Convention Center   |   San Francisco, CA Triconference.com/Digital-Pathology Bristol-Myers Squibb and Genentech to Present on Benefits of Multiplex Immunohistochemistry at CHI's Digital...